These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37079399)

  • 1. Crystal engineering of ionic cocrystals comprising Na/K salts of hesperetin with hesperetin molecules and solubility modulation.
    Jin S; Haskins MM; Deng CH; Matos CRMO; Zaworotko MJ
    IUCrJ; 2023 May; 10(Pt 3):329-340. PubMed ID: 37079399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal Engineering of Ionic Cocrystals Sustained by the Phenol-Phenolate Supramolecular Heterosynthon.
    Jin S; Sanii R; Song BQ; Zaworotko MJ
    Cryst Growth Des; 2022 Jul; 22(7):4582-4591. PubMed ID: 35935703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational Trimorphism in an Ionic Cocrystal of Hesperetin.
    Jin S; Haskins MM; Andaloussi YH; Ouyang R; Gong J; Zaworotko MJ
    Cryst Growth Des; 2022 Nov; 22(11):6390-6397. PubMed ID: 36345389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal Engineering of Ionic Cocrystals Sustained by Azolium···Azole Heterosynthons.
    Rahmani M; Kumar V; Bruno-Colmenarez J; Zaworotko MJ
    Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical cocrystals: along the path to improved medicines.
    Duggirala NK; Perry ML; Almarsson Ö; Zaworotko MJ
    Chem Commun (Camb); 2016 Jan; 52(4):640-55. PubMed ID: 26565650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming the Drawbacks of Sulpiride by Means of New Crystal Forms.
    Birolo R; Bravetti F; Bordignon S; D'Abbrunzo I; Mazzeo PP; Perissutti B; Bacchi A; Chierotti MR; Gobetto R
    Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs.
    Bolla G; Sarma B; Nangia AK
    Chem Rev; 2022 Jul; 122(13):11514-11603. PubMed ID: 35642550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supramolecular Synthon Promiscuity in Phosphoric Acid-Dihydrogen Phosphate Ionic Cocrystals.
    Haskins MM; Lusi M; Zaworotko MJ
    Cryst Growth Des; 2022 May; 22(5):3333-3342. PubMed ID: 35529065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal engineering of green tea epigallocatechin-3-gallate (EGCg) cocrystals and pharmacokinetic modulation in rats.
    Smith AJ; Kavuru P; Arora KK; Kesani S; Tan J; Zaworotko MJ; Shytle RD
    Mol Pharm; 2013 Aug; 10(8):2948-61. PubMed ID: 23730870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Failure of Cocrystallization Actually a Failure? Eutectic Formation in Cocrystal Screening of Hesperetin.
    Chadha K; Karan M; Chadha R; Bhalla Y; Vasisht K
    J Pharm Sci; 2017 Aug; 106(8):2026-2036. PubMed ID: 28456725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocrystals of acyclovir with promising physicochemical properties.
    Sarkar A; Rohani S
    J Pharm Sci; 2015 Jan; 104(1):98-105. PubMed ID: 25407552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal Structure, Solubility, and Pharmacokinetic Study on a Hesperetin Cocrystal with Piperine as Coformer.
    Liu Y; Yang F; Zhao X; Wang S; Yang Q; Zhang X
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35056990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural variety of heterosynthons in linezolid cocrystals with modified thermal properties.
    Khalaji M; Wróblewska A; Wielgus E; Bujacz GD; Dudek MK; Potrzebowski MJ
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2020 Oct; 76(Pt 5):892-912. PubMed ID: 33017322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salts of Amoxapine with Improved Solubility for Enhanced Pharmaceutical Applicability.
    Joshi M; Roy Choudhury A
    ACS Omega; 2018 Feb; 3(2):2406-2416. PubMed ID: 30023832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel furosemide cocrystals and selection of high solubility drug forms.
    Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
    J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isostructural cocrystals of metaxalone with improved dissolution characteristics.
    Gohel SK; Palanisamy V; Sanphui P; Prakash M; Singh GP; Chernyshev V
    RSC Adv; 2021 Sep; 11(49):30689-30700. PubMed ID: 35479860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards the systematic crystallisation of molecular ionic cocrystals: insights from computed crystal form landscapes.
    Mohamed S; Alwan AA; Friščić T; Morris AJ; Arhangelskis M
    Faraday Discuss; 2018 Oct; 211(0):401-424. PubMed ID: 30058649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocrystals, Salts, and Salt-Solvates of olanzapine; selection of coformers and improved solubility.
    Gong W; Mondal PK; Ahmadi S; Wu Y; Rohani S
    Int J Pharm; 2021 Oct; 608():121063. PubMed ID: 34481007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advancements in Pharmaceutical Cocrystals, Preparation Methods, and their Applications.
    Manchanda D; Kumar A; Nanda A
    Curr Pharm Des; 2021; 27(44):4477-4495. PubMed ID: 33858309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.